MTOR and primary cutaneous T-cell non-Hodgkin lymphoma: mTOR pathway dysregulation leads to uncontrolled epidermal-proliferation and -inflammation, especially in psoriasis, atopic dermatitis, pemphigus, acne, cutaneous T cell lymphoma, and melanoma.